|Home | About | Journals | Submit | Contact Us | Français|
This study aims to evaluate the sleep quality, architecture, sleep-related quality of life, and sleep-disordered breathing (SDB) in acute respiratory distress syndrome (ARDS) survivors early after discharge.
In this prospective, observational study, consecutive patients with ARDS discharged from the Intensive Care Unit (ICU) underwent evaluation with Epworth sleepiness scale (ESS), Pittsburgh Sleep Quality Index (PSQI), Functional Outcomes of Sleep Questionnaire (FOSQ), and overnight polysomnography. Patients having one or more of the following characteristics were classified as having abnormal sleep: ESS>10, PSQI>5, FOSQ <17.9, apnea–hypopnea index (AHI) ≥5, or AHI during rapid eye movement (REM) sleep ≥5.
Twenty patients (median interquartile range [IQR] age of 24 [22–28] years, 11 [55%] females) were included in the study. Acute febrile illness of unknown etiology with multi-organ dysfunction syndrome was the most common underlying etiology for ARDS. The median (IQR) PaO2/FiO2 ratio and APACHE II scores on admission were 176 (151–191.5) and 14 (14–16), respectively. The median (IQR) duration of stay in the ICU was 10 days (7.3–19.5). The overall sleep efficiency (median [IQR], 54% [32.3–65.4%]) was poor. None of the patients had ESS>10, seven (35%) had global PSQI>5 and one had FOSQ <17.9. Ten (50%) patients had at least one characteristic that suggested abnormal sleep (4 insomnia, 2 central sleep apnea, 1 obstructive sleep apnea, 1 REM-SDB, and 2 with a high PSQI, but no specific sleep abnormality).
Sleep disturbances are common in ARDS survivors early after discharge from the ICU.
Sleep disturbances are encountered in critically ill patients admitted to the Intensive Care Unit (ICU). The etiology is multifactorial including the acute illness itself, noisy environment of the ICU, exposure to light during the night, interruptions due to patient care-related activities, altered circadian rhythm, medications, and others.[1,2,3,4,5,6] Patients with the acute respiratory distress syndrome (ARDS) have severe acute illness, require mechanical ventilation in a majority of the instances. They are predisposed to the risk of patient-ventilator dyssynchrony and frequently require sedatives and other psychotropic medications. All these factors make them a unique population, especially prone to sleep disturbances. Severe disruptions have been reported in the sleep architecture in this subgroup of patients. Sleep disturbance that arises during the stay in the ICU may continue long after discharge. Survivors of ARDS suffer from many adverse physical and psychological sequelae and decreased quality of life. Chronic sleep disorders such as insomnia and sleep apnea present several months after discharge in these patients and contribute to the impaired quality of life.[8,10]
Sleep architecture has been previously studied in ARDS patients during the stay in the ICU. Chronic sleep disorders have been described in the survivors of ARDS several months after discharge.[8,10] Sleep disturbances have also been studied in the general population of critically ill patients both in the early and late postdischarge periods. We wanted to determine the prevalence of sleep disturbances diagnosed on the basis of a composite criterion in a uniform study population (of subjects with ARDS) early in the postdischarge period. In this study, we describe the changes in sleep quality, sleep-related quality of life, sleep architecture, and the prevalence of sleep-disordered breathing (SDB) in the survivors of ARDS early after discharge. We also perform a systematic review of studies describing sleep disturbances in patients discharged from ICUs after recovery from critical illness (with or without ARDS).
This was a prospective observational study conducted between July 2011 and September 2012 in the Department of Pulmonary Medicine of this institute. All patients provided informed consent and the study protocol was approved by the Ethics Review Committee.
Patients were included in the study if they satisfied all the following criteria: (i) Age 18–65 years, (ii) ARDS defined by the American-European Consensus Conference criteria, (iii) ICU stay of at least 48 h duration, (iv) intubated and mechanically ventilated for ≥24 h, (v) successfully extubated and discharged from the respiratory ICU after weaning from mechanical ventilation and survived for ≥1 month, and (vi) provided an informed consent to participate in the study. Patients with any of the following characteristics were excluded: (i) Known psychiatric, neurological, cognitive, or sleep disorder prior to the present illness, (ii) receiving any sedative or psychotropic medication after discharge from the ICU, (iii) discharge after getting tracheostomized, and (iv) failure to provide an informed consent. Patients were enrolled and all the study procedures were conducted at 1 month of discharge from the ICU.
The respiratory ICU comprises eight beds, has a nurse: Patient ratio of 1:2, and is overseen by a team of six pulmonary and critical care consultants. The nursing care is provided by a qualified nurse with assistance from the hospital attendants under the direct supervision of the doctors on duty (two pulmonary fellows at all times throughout the day and night). All patients are subjected to appropriate laboratory investigations and therapeutic management during their stay according to the ICU protocols.[13,14]
Demographic details (age, gender, and body mass index [BMI]) were recorded for all the included patients. The etiology of ARDS and the PaO2/FiO2 ratio at presentation were noted. All of them underwent endotracheal intubation and mechanical ventilation. Assist-control (volume controlled) mode of ventilation was used for all patients during the initial phase according to the ARDSNet protocol whereas pressure support ventilation was employed during the weaning period. The duration of ICU stay and mechanical ventilation, the dose and duration of sedatives and neuromuscular blockers, and the respective cumulative doses were recorded. The severity of the illness was assessed with the APACHE II score calculated within 24 h of ICU stay.
All patients completed the Epworth Sleepiness Scale (ESS), a self-administered questionnaire which rates the likelihood of falling asleep (from 0 to 3) under eight different daily life situations. The maximum score is 24 and a score above 10 indicates significant daytime sleepiness. The patients also responded to the Pittsburgh Sleep Quality Index (PSQI), a scale used for the subjective assessment of sleep quality. The questionnaire consists of 19 items with responses arranged on an integer scale from 0 to 3, which assesses seven components of sleep quality: Subjective sleep quality, latency, duration, and efficiency; sleep disturbances, sleeping medication use, and daytime dysfunction. The total sleep quality score, obtained by adding the component scores, ranges between 0 and 21, with higher scores representing lower sleep quality. A score above 5 indicates poor sleep quality. The scale can be adapted to enable the subject to respond verbally to items on the scale by having an interviewer read the statement to the subjects. Finally, the study participants also completed the Functional Outcomes of Sleep Questionnaire (FOSQ), which comprises 30 items, each item coded on a five-point scale (from 0 to 4). It assesses the impact of excessive sleepiness in five domains: Activity level, vigilance, intimacy and sexual relationships, general productivity, and social outcome. The total score ranges from 5 to 20 and a score of more than 17.9 is used as the threshold for defining a normal sleep-related quality of life. All the questionnaires were in English. All study participants completed the questionnaires under supervision (and if needed with some help from the interviewer), following a detailed explanation.
An overnight polysomnography (PSG) was performed on all study subjects within a month of discharge from the ICU. Monitoring of the electroencephalogram using two frontal, two central, and two occipital channels (placed according to the international 10–20 system), electro-oculogram, submental and anterior tibialis electromyogram, electrocardiogram (lead I), chest and abdominal movements, airflow (using oronasal thermal sensor and nasal air pressure transducer), and pulse oximetry was performed. Sleep scoring was done according to 2007 American Academy of Sleep Medicine criteria. Apnea–hypopnea index (AHI) was calculated for each patient. The total sleep duration, duration of each sleep stage, and sleep efficiency were calculated. AHI during rapid eye movement (REM) sleep (AHI-REM) was also separately calculated. SDB was defined by AHI ≥5, while SDB-REM was defined by an AHI-REM ≥5.
Patients having one or more of the following characteristics were classified as having abnormal sleep: ESS>10, PSQI>5, FOSQ <17.9, AHI ≥5, or AHI-REM ≥5.
Statistical analysis was performed using the commercial statistical package SPSS (Version 22 for MS-Windows, IBM Corp., Armonk, New York, USA). Continuous data are expressed as mean (standard deviation [SD]) or median (interquartile range [IQR]), based on the Shapiro–Wilk test of normality, whereas categorical data are expressed as number with percentage. Differences in continuous variables between two groups were compared using the Mann–Whitney U-test. P <0.05 was considered statistically significant.
A total of 360 patients were admitted to the respiratory ICU during the study period; 74 (20.6%) had a diagnosis of ARDS, of which 50 (67.6%) patients survived their ICU stay. Of these, eight fell outside the age limits of the study, five had known psychiatric and/or sleep disorders, three were managed on noninvasive ventilation, five patients were discharged on a tracheostomy, four patients died within 1 month of discharge, and five patients refused to provide informed consent. Finally, twenty patients (median [IQR] age 24 [22–28] years, 11 [55%] females) were enrolled in this study [Table 1]. Acute febrile illness of unknown etiology with multi-organ dysfunction syndrome was the most common underlying etiology for ARDS. The median (IQR) PaO2/FiO2 ratio and APACHE II scores were 176 (151–191.5) and 14 (14–16), respectively. The median (IQR) duration of stay in the ICU was 10 (7.3–19.5) days. Midazolam (14 [70%] patients) and vecuronium (12 [60%] patients) were the most commonly employed sedative and neuromuscular blocking agents, respectively.
None of the patients had an ESS score (median [IQR] score of 6 [3.3–7]) of more than 10 [Table 2]. Seven (35%) patients had a global PSQI above the threshold score of 5, representing poor overall sleep quality. The mean (SD) global FOSQ was 18.37 (0.62), with only one patient having a FOSQ score below the conventionally used cutoff of 17.9. Ten (50%) patients did not respond to the sexual and intimacy component of the FOSQ scale. The overall sleep efficiency (median [IQR], 54% [32.3–65.4%]) was poor [Table 3]. Most of the sleep duration comprised stage 1 and 2, while slow wave and REM sleep together accounted for 21.4% (median) of the total sleep duration. The median (IQR) AHI was 1.9 (0.7–2.7). Three (15%) and six (30%) patients had AHI and AHI-REM ≥ 5, respectively [Table 3]. Overall, ten (50%) of the twenty patients had at least one of the following characteristics signifying abnormal sleep: ESS>10, PSQI>5, FOSQ <17.9, AHI ≥5, or AHI-REM ≥5. Of these, four had insomnia (all had complaints of difficulty initiating sleep), two had central sleep apnea, and one had obstructive sleep apnea (OSA). In one patient, REM SDB was the predominant abnormality detected. In two other patients, the PSQI was high; however, no specific sleep abnormality could be identified. On comparing the characteristics of subjects with (n = 3) and without (n = 17) SDB (i.e. AHI ≥ 5), those with SDB had a longer duration of receiving sedation in the ICU (P = 0.048) with higher cumulative doses of midazolam (P = 0.044) administered.
This study demonstrates that at least one parameter representing abnormal sleep is present in half of the mechanically ventilated ARDS patients early after discharge from the ICU. In this study, we adopted a multi-pronged approach in an attempt to capture the different aspects of sleep disturbances including daytime sleepiness (using ESS), sleep quality (using PSQI), sleep-related quality of life (using FOSQ), and specific sleep abnormalities such as SDB (using PSG). To our knowledge, this is the first study in which an unselected group of ARDS patients has been evaluated early in the post-ICU discharge period, irrespective of the presence or absence of any sleep-related complaints.
We searched the PubMed and EMBASE databases for relevant studies describing the occurrence of sleep disturbances after recovery from critical illness (with or without ARDS) using the following search terms: (“sleep disordered breathing” OR “sleep apnoea” OR “sleep apnoea” OR “sleep quality” OR “sleep-related quality of life” OR “sleep disorders” OR “sleep disturbances”) AND (”acute respiratory distress syndrome” OR “ards” OR “adult respiratory distress syndrome” OR “acute lung injury” OR “critical illness” OR “critically ill” OR “intensive care” OR “ICU” OR “mechanical ventilation” OR “mechanically ventilated”). From the EMBASE database, citations under only the two categories, “articles” and “articles in press” were included. We reviewed the list of references of original studies, editorials, and reviews; and also sifted through our personal files. We excluded case reports, abstracts, comments, editorials, and reviews; studies describing the quality of sleep or sleep disturbances during ICU stay; studies describing the outcomes of patients with known sleep disorders (e.g., OSA); studies performed only in the pediatric population; and studies performed in noncritically ill hospitalized patients or in postoperative subjects.
The initial database search yielded 991 studies, of which 17 studies (2314 subjects) met the inclusion criteria [Figure 1 and Table 4].[8,11,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35] The instruments used to assess sleep disorders/disturbances varied widely from unstructured questionnaires to specific instruments, while PSG was performed in only four studies.[8,23,29,31] Most studies described the proportion of patients having poor sleep quality, sleep disturbances, or sleep-related symptoms, while the studies in which PSG was performed also reported sleep efficiency, sleep latency, sleep architecture, and/or AHI [Table 5]. Fourteen studies reported the percentage of patients with abnormal sleep (subjective or objective).[8,11,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35] Six of these were performed early (<1 month) and five late (>1 month) after discharge while three studies reported on both early and late outcomes [Table 6]. The median (range) percentage of patients having abnormal sleep was higher in the early period (66.7% [40.4–80%]) than in the late period (38.5% [6.4–57%]).
For the present study, we selected a specific subgroup of subjects among the patient population in the ICU, i.e., those with ARDS. This group is relatively uniform since nearly all these patients require invasive mechanical ventilation and many of them have multi-organ dysfunction. A previous study on sleep disturbances in ARDS survivors showed that 6.4% of the subjects reported persistent sleep-related symptoms 6 months or more following discharge from the ICU. In contrast, in the present study where consecutive ARDS survivors were included much earlier in the postdischarge period (within a month), a remarkably higher prevalence (50%) of abnormal sleep was found. One contributing factor for finding a high prevalence of abnormal sleep is that a broad definition of abnormal sleep was considered in the present study. We have used multiple parameters (3 questionnaires and PSG) so as to be able to capture a higher proportion of patients with any type of sleep disturbance/reduced sleep quality/reduced sleep-related quality of life. The prevalence of abnormal sleep found in this study is consistent with the results of the systematic review in which 40–80% of critically ill patients had evidence of sleep disturbances within a month of discharge from the ICU. The most common sleep disorder was insomnia as in other studies.[8,26,30]
The reason why sleep disruption is so common early in the recovery period is uncertain. While it is well known that many environmental factors such as sound, light, ventilator, and patient care activities disrupt sleep in patients during their stay in the ICU, it is possible that the sleep pattern associated with critical illness and admission to the ICU may continue to persist for some period after discharge.[1,11] This type of sleep disruption originating during ICU admission possibly extends into the recovery period and gradually resolves in a proportion of the patients as time elapses. As evident from the systematic review, the proportion of patients reported to have sleep disruption was higher in the early period (median 67%), climbing down to 39% in the late period. The findings from the present study and the systematic review suggest that greater attention must be paid to sleep parameters during the early follow-up period of ARDS patients discharged from the ICU. Sleep disturbances should be specifically looked for and managed accordingly; this might help in improving the sleep-related quality of life.
Seven of our patients had a global PSQI higher than the threshold value of 5 suggesting a poor overall sleep quality. Yet none of our patients had an ESS>10 suggesting that ESS that assessed only subjective excessive daytime sleepiness may be a poor measure of assessing sleep disturbances in this population. The PSQI questionnaire is more comprehensive and assesses the sleep quality based on seven different components, and hence is more robust. A previous study that employed the PSQI also found that poor sleep quality in a high proportion (70%) of patients at 1–2 day after discharge from the ICU. Contrarily, the global FOSQ was higher than 17.9 in most of the patients in our study, suggesting a good sleep-related quality of life. One of the possible reasons for this incongruity is that half of our patients did not respond to the sexual and intimacy component of the scale as sex-related issues are considered taboo for a large number of individuals in our community.
SDB was observed in only 3 (15%) of the patients in the current study, in contrast to the findings of Chishti et al., in which 73% of the patients had AHI>5. The potential reason for the discrepancy is that in studies of ICU survivors, it is not possible to ascertain whether the SDB was preexisting or appeared after the acute illness. Furthermore, the prevalence of SDB is higher with increasing age and BMI. In the present study, both the median age (24 years) and the median BMI (20.0 kg/m2) of the patients were low. Due to this reason, the subjects in our study had a lower probability of having preexisting OSA, although factors different from BMI and age (such as craniofacial characteristics) might still play a role. In our study, we found that patients with SDB had a significantly longer duration of receiving sedation in the ICU with higher cumulative doses of midazolam. Whether a preexisting SDB led to prolonged requirement of mechanical ventilation or SDB appeared as a result of prolonged sedation and higher doses of midazolam cannot be ascertained. Besides, the number of subjects with SDB in this study is too few for a definite conclusion.
We found low sleep efficiency (median 54%) in survivors of ARDS similar to the findings in previous studies.[8,29,31] Further, most sleep occurred in stage 1 and 2 in our patients with markedly reduced restorative sleep (REM and slow wave sleep) as in previous reports.[8,31] This again probably reflects the persistence of sleep abnormalities such as reduced REM and slow wave sleep that originate during the ICU stay. The finding of a high prevalence (30%) of REM-related SDB in ARDS survivors needs further confirmation in a larger study cohort.
Our study has a few limitations including a small sample size. The study population mainly consists of predominantly young individuals with tropical illnesses as the cause of ARDS, thus the results may not be generalizable to other patient groups. We did not follow-up the patients over time; therefore, we cannot draw conclusions on whether the early changes in sleep quality lead to any symptomatic sleep disruption over a longer period of time. The strengths of our study include the prospective data collection in an unselected group of ARDS patients soon after discharge from the ICU.
Our study found a high prevalence of abnormal sleep in survivors of ARDS early after discharge from the ICU. The prevalence of sleep abnormalities found is lesser in studies performed late as compared to the early postdischarge period as is evident from the systematic review.
There are no conflicts of interest.
The authors fondly remember and heartily thank Late Prof. Dheeraj Gupta, Department of Pulmonary Medicine, Chandigarh, India, for overseeing this study.